Recent studies are beginning to delineate those pathways by which the important pathogen Candida albicans switches from one growth form to another; at the same time, insights are being gained into the importance of growth form in pathogenesis.
One of the most remarkable aspects of C. albicans biology is its ability to assume a variety of cell morphologies ( Figure 1 ). These range from yeast-like cells to a variety of elongated growth forms, including a thread-like hyphal growth form, germ tubes -during the transition between yeast and hyphae -and pseudohyphae, which vary in shape from attached strings of yeast-like cells to long filaments with constrictions at the septa. The yeast form is the one commonly found in the laboratory; the transition to elongated growth is promoted by a wide range of environmental conditions, including growth at 37°C, exposure to serum or a neutral pH.
It has long been suspected that this polymorphism is an important facet of C. albicans pathogenesis, although it has not been clear whether it is any one growth form that is required for infection, or whether simply having the potential for phenotypic plasticity is important. Two recent studies [1, 2] have finally provided some strong experimental support for the notion that the capacity for hyphal formation is critical for Candida pathogenesis, at least in a mouse model, while another study [3] promises to answer the complementary question of whether yeast phase growth is also required for Candida infection.
Proof that a molecule or a property is a virulence factor has generally relied on genetic strategies in which mutants are generated and virulence compared with otherwise isogenic wild-type strains. For C. albicans this is far from simple, as the organism is diploid and lacks a sexual cycle. Genetic analysis has been made more tractable through the development of transformation and sequential gene disruption procedures that employ reusable gene cassettes. Nonetheless, many previous attempts to demonstrate C. albicans virulence factors can be criticized on the grounds that, although they may have demonstrated reduced virulence of a mutant derivative with respect to the parental strain, they failed to demonstrate restoration of full virulence when the wildtype gene is reintroduced into the mutant. Thus, changes in virulence might have occurred simply through accumulation of undetected (and undesired) changes during the multiple steps required to inactivate the two copies (or more in the case of gene families) of the target gene.
These criticisms have largely been dealt with in the paper by Leberer and colleagues [1] , and they provide convincing evidence that hypha formation is required for C. albicans infection in a model in which mice are infected intravenously with yeast cells. They followed a strategy that is rapidly becoming the norm for Candida studies, in which our ever-increasing knowledge about the related non-pathogenic -but far more genetically tractable -yeast Saccharomyces cerevisiae is used to formulate educated guesses about mechanisms that are likely to operate in C. albicans. Candida genes relevant to the current discussion of morphogenesis, and their Saccharomyces counterparts are listed in Table 1 . Leberer and colleagues [1] reasoned that members of the Ste20 family of serine/threonine protein kinases, which are involved in triggering morphogenetic processes in a wide range of organisms, are excellent candidate regulators of C. albicans morphogenesis.
In a previous study, Leberer and colleagues [4] disrupted the C. albicans STE20 homolog CST20 and showed that, although the strain was impaired for morphogenesis under some induction conditions, it was still capable of forming hyphae in serum at 37°C. The virulence of the cst20 mutants, assessed in a mouse model, was reduced, but not completely eliminated. This led them to focus their attention on the other well characterized member of the STE20 family in S. cerevisiae, CLA4 [1] .
When both copies of the C. albicans CLA4 gene were disrupted, the mutants were unable to form hyphae under a wide range of induction conditions, including incubation in serum at 37°C. Leberer and colleagues [1] further demonstrated that the cla4 mutant is avirulent in a mouse model. And significantly, virulence was restored to the mutant strain by transformation with a plasmid bearing a functional version of CLA4. Although it is still possible that a function of CLA4 other than in morphogenesis is required for infection, the unaffected growth rate of the mutant when grown under laboratory conditions provides a strong argument that it is not grossly impaired for general cellular processes.
In addition to its contribution to our understanding of the role of hyphae in pathogenesis, this paper [1] is important because it demonstrates that plasmids can be used to restore the wild-type phenotype of C. albicans mutants in vivo. As the plasmids presently available for use in C. albicans are relatively unstable, investigators have hesitated to use them in virulence experiments. Leberer and coworkers [1] have shown that this approach is a feasible one, opening the door to a more vigorous testing of the virulence properties of isolated genes.
How might CLA4 be involved in the dimorphic transition of C. albicans, and what are some of the other key players in C. albicans morphogenesis? As mentioned above, CLA4 encodes a member of the Ste20 family of proteins. In S. cerevisiae, Ste20 proteins are known to participate in the mitogen-activated protein (MAP) kinase pathway, which is required for pseudohyphal induction in response to nitrogen starvation. Two other C. albicans genes that act in this pathway have now been identified -HST7 and CPH1/ACPR, homologs of S. cerevisiae genes STE7 and STE12, respectively -and mutants lacking those functions have been generated [4] [5] [6] . These mutants resembled the cst20 mutant, in that they showed impaired hyphal induction only under certain conditions and were able to form hyphae in serum at 37°C, possibly indicating that more than one pathway can lead to hyphal formation in Candida.
Additional support for the concept of parallel pathways leading to hyphal formation comes from an analysis of cph1 efg1 double mutants [2] . EFG1 was first detected in a screen for Candida genes that cause enhanced filamentous growth when overexpressed in S. cerevisiae [7] . The EFG1 protein sequence suggests that it is a Myc-like transcription factor with a basic helix-loop-helix motif [7] . EFG1 is also similar to three other fungal genes implicated in morphogenesis: StuA of Aspergillus nidulans, which is required at several different developmental stages [8] , and PHD1 and SOK2 of S. cerevisiae. Like EFG1, PHD1 is an enhancer of filamentation in S. cerevisiae, whereas SOK2 inhibits filamentation. Candida efg1 mutants were observed to form abundant pseudohyphae, but not hyphae, in response to serum [2] . The double mutant cph1 efg1, however, failed to produce germ tubes and hyphae under any conditions tested [2] , a phenotype reminiscent of the cla4 mutant.
Like the non-filamentous cla4 mutant, the cph1 efg1 double mutant was avirulent at an inoculum size that with the wild-type strain killed 50% of mice six days after injection. At higher inoculum levels, the cph1 efg1 double mutant showed greatly attenuated virulence. Furthermore, the double mutant showed a profound defect in its response to phagocytosis by a macrophage-like cell line. Whereas wildtype Candida responds to phagocytosis with a rapid switch to the hyphal growth form that leads to piercing of the macrophage from within, the double mutant remains in the yeast form, and the macrophage continues to ingest further yeast cells without any apparent ill-effects.
The cph1 and efg1 single mutants were each virulent in the mouse model and exhibited hyphal formation in response to phagocytosis, although the efg1 mutant was noticeably impaired in both processes. One of us recently proposed a model for pseudohypha formation that put CPH1 and EFG1 in the same pathway [9] . This aspect of the model is rendered considerably less likely by the results of Lo et al. [2] . It is more likely that CPH1 and EFG1 act in separate, but parallel, pathways that lead to hyphal induction, and it is only when both pathways are eliminated that hyphal induction is completely abolished. Consistent with this model, CLA4 might be a common element in both pathways.
A puzzling contradiction between the results of Lo et al. [2] and those of Stoldt et al. [7] is that the latter group was unable to generate a homozygous disruption of efg1 and concluded that this gene might be essential. In principle, there are several possible reasons for this discrepancy, but some are very unlikely. For example, Stoldt et al. [7] were able to disrupt one allele, so it is unlikely that they had made a dominant lethal disruption. As they inserted ADE2 into the EFG1 gene, they probably did not disrupt an adjacent gene. Lo et al. [2] did not remove all the coding region of EFG1, so they may have had some residual activity. Finally, there may be strain differences; although the two strains used -CAI4 by Lo et al. [2] and CAI8 by Stoldt et al. [7] -are closely related, they are not isogenic.
Resolving the question of whether EFG1 is an essential gene is certainly important in elucidating the pathways in which it is involved.
If, as it appears, hyphal growth is a requirement for efficient Candida infection in the mouse model, can we say anything about the role of yeast phase growth in infection?
One way to address this question would be to examine the virulence of a strain unable to grow in the yeast form.
A strain with such a phenotype was described recently by Braun and Johnson [3] , who found that deletion of C. albicans TUP1 leads to constitutive hyphal formation. In S. cerevisiae, Tup1 protein acts as a transcriptional repressor, and tup1 mutants show pleiotropic phenotypes, most of which can be complemented by overexpression of the C. albicans TUP1. This argues that the TUP1 function is highly conserved between the two species, even to the level of its interactions with the DNA-binding proteins that are thought to enable TUP1 to repress selected subsets of genes. In S. cerevisiae, elimination of TUP1 activity does not lead to constitutive pseudohyphal growth; rather, it decreases the propensity for strains to form pseudohyphae under nitrogen starvation conditions. The differences in TUP1 activity between the two species are presumably due to differences either in the regulation of the DNA-binding proteins with which Tup1 interacts, or in the subset of genes that are regulated by Tup1 complexes.
It appears that, in C. albicans, TUP1 plays a central role in morphogenesis, as the tup1 mutant grows as hyphae or pseudohyphae under all conditions so far examined. The tup1 genotype appears incompatible with the yeast growth form, a more extreme phenotype than has been observed for other mutants that show partially constitutive hyphal growth. Significantly, tup1 cph1 double mutants show the tup1 phenotype, suggesting that TUP1 acts downstream of CPH1. An attractive model is that multiple input signals converge on the set of genes involved in pseudohyphal or hyphal growth, which are negatively regulated by TUP1. Some of these genes might include repressors of the yeast growth phase. As to whether the constitutively hyphal tup1 mutant is pathogenic, at present we must be satisfied with a tantalizing footnote in which Braun and Johnson [3] report preliminary data indicating that the tup1 mutant is far less pathogenic in mice than the parental strain. They caution, however, that this could be due to defects unconnected to morphology.
Notwithstanding the differences that are emerging between S. cerevisiae and Candida morphogenesis, the strategy of using S. cerevisiae data to guide Candida experiments is clearly a highly productive one. Where is the S. cerevisiae work now pointing? One obvious area of interest is that of the role of 14-3-3 proteins, which are found in a wide range of organisms and have now been shown to have a role in S. cerevisiae pseudohyphal development [10] . In S. cerevisiae, the 14-3-3 homologs Bmh1 and Bmh2 are essential for the MAP kinase cascade leading to pseudohyphal development, but not the pheromone-induced MAP kinase cascade. It is conceivable that the various pathways leading to hyphal and pseudohyphal development in Candida will similarly involve combinatorial effects of 14-3-3 homologs and other proteins with various components of the MAP kinase pathway that have already been identified.
We are faced, then, with weaving together the different strands of Candida morphogenesis into a tapestry of genetic interactions and transcription loops. When we have succeeded in that task, if not before, we can begin the process of unravelling the tapestry in vivo through use of drugs that target key enzymes in the hyphal growth pathway. The Cla4 and Tup1 proteins are worthwhile places to start searching for inhibitors, and many more possible targets are sure to follow soon. It will be interesting to see whether inhibitors that selectively block morphogenetic processes in Candida offer any advantages over current antifungals that are fungicidal or fungistatic towards all growth forms of the organism.
